Human Monotard

What is it?

A preparation of human, intermediate-acting insulin comprising human insulin zinc suspension (pyr) which is highly purified, 100iu. per ml, available in vials for injection.

Medical Uses

Diabetes.

Dosage

According to individual patient requirements; usually self-administered by subcutaneous or intramuscular injection.

Special Care

Kidney or liver disease, patients transferring from animal insulins (should be warned that early signs of hypoglycaemia may not be so apparent). Infections, illnesses, stress, emotional upset, pregnancy, change in insulin source, type etc; in all these cases, dose adjustments may be needed.

Possible Drug and Food Interactions

Oral contraceptives, MAOIs, alcohol, 1-blockers, corticotrophin, diuretics, corticosteroids.

Known Side Effects

Lipodystrophy (changes involving fat deposition) at injection site.

Manufacturer

Novo Nordisk.